Literature DB >> 33374621

The cGMP-Dependent Protein Kinase 2 Contributes to Cone Photoreceptor Degeneration in the Cnga3-Deficient Mouse Model of Achromatopsia.

Mirja Koch1, Constanze Scheel1, Hongwei Ma2, Fan Yang2, Michael Stadlmeier3, Andrea F Glück3, Elisa Murenu1,4, Franziska R Traube3, Thomas Carell3, Martin Biel1, Xi-Qin Ding2, Stylianos Michalakis1,4.   

Abstract

Mutations in the CNGA3 gene, which encodes the A subunit of the cyclic guanosine monophosphate (cGMP)-gated cation channel in cone photoreceptor outer segments, cause total colour blindness, also referred to as achromatopsia. Cones lacking this channel protein are non-functional, accumulate high levels of the second messenger cGMP and degenerate over time after induction of ER stress. The cell death mechanisms that lead to loss of affected cones are only partially understood. Here, we explored the disease mechanisms in the Cnga3 knockout (KO) mouse model of achromatopsia. We found that another important effector of cGMP, the cGMP-dependent protein kinase 2 (Prkg2) is crucially involved in cGMP cytotoxicity of cones in Cnga3 KO mice. Virus-mediated knockdown or genetic ablation of Prkg2 in Cnga3 KO mice counteracted degeneration and preserved the number of cones. Analysis of markers of endoplasmic reticulum stress and unfolded protein response confirmed that induction of these processes in Cnga3 KO cones also depends on Prkg2. In conclusion, we identified Prkg2 as a novel key mediator of cone photoreceptor degeneration in achromatopsia. Our data suggest that this cGMP mediator could be a novel pharmacological target for future neuroprotective therapies.

Entities:  

Keywords:  achromatopsia; cGMP cytotoxicity; cone photoreceptor; neuroprotection; photoreceptor degeneration

Mesh:

Substances:

Year:  2020        PMID: 33374621      PMCID: PMC7793084          DOI: 10.3390/ijms22010052

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   6.208


  43 in total

1.  cGMP accumulation causes photoreceptor degeneration in CNG channel deficiency: evidence of cGMP cytotoxicity independently of enhanced CNG channel function.

Authors:  Jianhua Xu; Lynsie Morris; Arjun Thapa; Hongwei Ma; Stylianos Michalakis; Martin Biel; Wolfgang Baehr; Igor V Peshenko; Alexander M Dizhoor; Xi-Qin Ding
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  Impaired opsin targeting and cone photoreceptor migration in the retina of mice lacking the cyclic nucleotide-gated channel CNGA3.

Authors:  Stylianos Michalakis; Heidi Geiger; Silke Haverkamp; Franz Hofmann; Andrea Gerstner; Martin Biel
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

Review 3.  The cGMP system: components and function.

Authors:  Franz Hofmann
Journal:  Biol Chem       Date:  2020-03-26       Impact factor: 3.915

4.  Nrl is required for rod photoreceptor development.

Authors:  A J Mears; M Kondo; P K Swain; Y Takada; R A Bush; T L Saunders; P A Sieving; A Swaroop
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

Review 5.  DNA damage kinase signaling: checkpoint and repair at 30 years.

Authors:  Michael Charles Lanz; Diego Dibitetto; Marcus Bustamante Smolka
Journal:  EMBO J       Date:  2019-08-08       Impact factor: 11.598

Review 6.  Cellular mechanisms of hereditary photoreceptor degeneration - Focus on cGMP.

Authors:  Michael Power; Soumyaparna Das; Karin Schütze; Valeria Marigo; Per Ekström; François Paquet-Durand
Journal:  Prog Retin Eye Res       Date:  2019-07-30       Impact factor: 21.198

7.  Globally optimal stitching of tiled 3D microscopic image acquisitions.

Authors:  Stephan Preibisch; Stephan Saalfeld; Pavel Tomancak
Journal:  Bioinformatics       Date:  2009-04-03       Impact factor: 6.937

Review 8.  Retinal Cyclic Nucleotide-Gated Channels: From Pathophysiology to Therapy.

Authors:  Stylianos Michalakis; Elvir Becirovic; Martin Biel
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

Review 9.  The cGMP Pathway and Inherited Photoreceptor Degeneration: Targets, Compounds, and Biomarkers.

Authors:  Arianna Tolone; Soumaya Belhadj; Andreas Rentsch; Frank Schwede; François Paquet-Durand
Journal:  Genes (Basel)       Date:  2019-06-14       Impact factor: 4.096

10.  Retinal structure and function in achromatopsia: implications for gene therapy.

Authors:  Venki Sundaram; Caroline Wilde; Jonathan Aboshiha; Jill Cowing; Colin Han; Christopher S Langlo; Ravinder Chana; Alice E Davidson; Panagiotis I Sergouniotis; James W Bainbridge; Robin R Ali; Alfredo Dubra; Gary Rubin; Andrew R Webster; Anthony T Moore; Marko Nardini; Joseph Carroll; Michel Michaelides
Journal:  Ophthalmology       Date:  2013-10-20       Impact factor: 12.079

View more
  2 in total

1.  In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa.

Authors:  Johanna E Wagner; Lena Zobel; Maximilian J Gerhardt; Catherine R O'Riordan; Amy Frederick; Simon M Petersen-Jones; Martin Biel; Stylianos Michalakis
Journal:  Hum Gene Ther       Date:  2021-09-20       Impact factor: 4.793

Review 2.  Achromatopsia: Genetics and Gene Therapy.

Authors:  Stylianos Michalakis; Maximilian Gerhardt; Günther Rudolph; Siegfried Priglinger; Claudia Priglinger
Journal:  Mol Diagn Ther       Date:  2021-12-03       Impact factor: 4.074

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.